Regulatory News: Elekta (STO:EKTAB) has been selected by two progressive Italian hospitals opening up new radiation therapy clinics, to supply advanced and clinically proven cancer treatment systems for intensity modulated and image guided radiation therapy (IMRT & IGRT).

The Japanese Ministry for Health, Labor and Welfare, MHLW, has given approval for the Elekta Synergy(R) (STO:EKTAB), the world-leading clinical solution for image guided radiation therapy (IGRT) and intensity modulated radiation therapy (IMRT).